Clinical Trial Update: Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating calaspargase pegol or pegaspargase with combination chemotherapy in younger patients with newly diagnosed high-risk acute lymphoblastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Calaspargase Pegol (calaspargase pegol)
• Pegaspargase (pegaspargase)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2018-09-06